| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2d80fb92361c6f163fc89c3dfec604e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4824
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-562
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B1-317 |
| filingDate |
2019-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52d59e24fba3e6747375e74397e2d7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e35a623d9ffa9f4c06a6e2db885876ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e917c77d91bf0acd604761104d60521d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feeded45d9ca45e4daa35ea54028a36b |
| publicationDate |
2021-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3905942-A1 |
| titleOfInvention |
Formulation for use in treating osteoarthritis |
| abstract |
A formulation for use in treating osteoarthritis by modifying the shape change of bone(s) underlying articular cartilage is disclosed. The use comprises evaluating the bone shape of the patient's joint, injecting the patient with a peptide of SEQ ID No. 1 or applying other therapeutic interventions that can reduce the shape change of the bone(s) underlying articular cartilage, and thereafter evaluating the bone shape of the patient's joint. |
| priorityDate |
2018-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |